Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/17/2023 | $9.50 | Neutral | Piper Sandler |
| 1/25/2023 | Buy → Neutral | Compass Point | |
| 8/30/2022 | $13.25 | Mkt Perform | Keefe Bruyette |
RUTHERFORD, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024, and a net loss of $2.8 million, or $0.13 per diluted common share, for the three months ended March 31, 2024. James D. Nesci, President and Chief Executive Officer, commented, "We are pleased with the improvement experienced in yields on assets and cost of liabilities as both contributed to a 27
RUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, April 30, 2025 it will release financial results for the quarter ended March 31, 2025. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, April 30, 2025 at 11:00AM (ET) to discuss First Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts. The c
RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), reported a net loss of $11.9 million, or $0.55 per diluted common share, for the year ended December 31, 2024 compared to a net loss of $7.4 million, or $0.31 per diluted common share for the year ended December 31, 2023. The Company reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024 compared to a net loss of $4.0 million, or $0.19 per diluted common share for the three months ended September 30, 2024, and a net loss of $2.9 million, or $0.13 per diluted common share
8-K - Blue Foundry Bancorp (0001846017) (Filer)
10-Q - Blue Foundry Bancorp (0001846017) (Filer)
SCHEDULE 13G - Blue Foundry Bancorp (0001846017) (Subject)
RUTHERFORD, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of John F. Kuntz, Esq. as a Director of both the Company and its subsidiary, Blue Foundry Bank, effective immediately. Kenneth Grimbilas, Chairman, stated, "We are very pleased to have Mr. Kuntz join Blue Foundry's Board of Directors. His extensive knowledge and experience in financial, legal and operational matters will provide additional perspective and depth to the organization. His experience with charitable foundations will also prove to be instrumental at Blue Foundry." Mr. Kuntz most recently served as Senior Executive Vice President and Chief Adm
RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately. James D. Nesci, President and Chief Executive Officer stated, "We are excited to welcome Ms. Jobes to Blue Foundry's Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry." Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Bef
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
RUTHERFORD, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended March 31, 2025, compared to net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024, and a net loss of $2.8 million, or $0.13 per diluted common share, for the three months ended March 31, 2024. James D. Nesci, President and Chief Executive Officer, commented, "We are pleased with the improvement experienced in yields on assets and cost of liabilities as both contributed to a 27
RUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, April 30, 2025 it will release financial results for the quarter ended March 31, 2025. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, April 30, 2025 at 11:00AM (ET) to discuss First Quarter 2025 Earnings. Blue Foundry Bancorp will address live questions from analysts. The c
RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), reported a net loss of $11.9 million, or $0.55 per diluted common share, for the year ended December 31, 2024 compared to a net loss of $7.4 million, or $0.31 per diluted common share for the year ended December 31, 2023. The Company reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024 compared to a net loss of $4.0 million, or $0.19 per diluted common share for the three months ended September 30, 2024, and a net loss of $2.9 million, or $0.13 per diluted common share
Piper Sandler initiated coverage of Blue Foundry Bancorp with a rating of Neutral and set a new price target of $9.50
Compass Point downgraded Blue Foundry Bancorp from Buy to Neutral
Keefe Bruyette initiated coverage of Blue Foundry Bancorp with a rating of Mkt Perform and set a new price target of $13.25
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)